Bioassay-guided fractionation of the organic extract from the marine sponge Acanthella costata resulted in the isolation of the known natural product, (-)-dibromophakellin (1). Using a fluorescence imaging plate reader (FLIPR) based assay, compound 1 was identified as displaying agonist activity against the alpha(2B) adrenoceptor, with an EC(50) of 4.2muM. Debromination and Suzuki-Miyaura coupling reactions were undertaken in order to provide structure activity data about the pyrrole ring of this marine metabolite. These synthetic studies generated the known natural product analogues, (-)-phakellin (2), and (-)-monobromophakellin (3), along with the new synthetic derivatives (-)-4-bromo-5-phenylphakellin (5) and (-)-4,5-diphenylphakellin (6). Substitution of the C-5 Br of 1 with H (2 and 3) or phenyl (5 and 6) resulted in loss of activity indicating that Br at C-5 is required for agonist activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2009.01.065DOI Listing

Publication Analysis

Top Keywords

alpha2b adrenoceptor
8
marine sponge
8
sponge acanthella
8
acanthella costata
8
natural product
8
agonist activity
8
--dibromophakellin alpha2b
4
adrenoceptor agonist
4
agonist isolated
4
isolated australian
4

Similar Publications

Centhaquine is a resuscitative agent that acts on α2B adrenergic receptors. Its effect on cardiac output in hypovolemic shock patients has not been reported. This pilot study was conducted in 12 hypovolemic shock patients treated with centhaquine who participated in an open-label phase IV study (NCT05956418).

View Article and Find Full Text PDF
Article Synopsis
  • Catecholamines interact with α- and β-adrenergic receptors on immune cells, influencing immune responses, particularly through α2-adrenergic receptors.
  • The study identifies AGN-762 as a selective agonist for the α2B and α2C subtypes, reducing disease symptoms in an experimental model of autoimmune disease by affecting T regulatory cells.
  • Importantly, AGN-762 does not cause the sedative or cardiovascular side effects typical of other α2A subtype agonists, suggesting its potential as a new treatment strategy for autoimmune conditions.
View Article and Find Full Text PDF

Endometritis is a common disease in animals, leading to disruption of reproductive processes and economic losses. Noradrenergic control of prostaglandin (PG)I2 formation by inflamed endometrium is unknown. We determined the involvement of α1-, α2- and β-adrenoreceptors (ARs) in noradrenaline-influenced PGI synthase (PGIS) protein abundance and PGI2 release from porcine (1) endometrial explants with ()-induced inflammation in vivo, and (2) lipopolysaccharide (LPS)-treated endometrial epithelial cells.

View Article and Find Full Text PDF

Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review).

Med Int (Lond)

February 2024

Department of Physiology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey.

Epilepsy is a complex and common neurological disorder characterized by spontaneous and recurrent seizures, affecting ~75 million individuals worldwide. Numerous studies have been conducted to develop new pharmacological drugs for the effective treatment of epilepsy. In recent years, numerous experimental and clinical studies have focused on the role of the adrenergic receptor (AR) system in the regulation of epileptogenesis, seizure susceptibility and convulsions.

View Article and Find Full Text PDF

Segregation of nascent GPCRs in the ER-to-Golgi transport by CCHCR1 via direct interaction.

J Cell Sci

February 2024

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

G protein-coupled receptors (GPCRs) constitute the largest superfamily of cell surface signaling proteins that share a common structural topology. When compared with agonist-induced internalization, how GPCRs are sorted and delivered to functional destinations after synthesis in the endoplasmic reticulum (ER) is much less well understood. Here, we demonstrate that depletion of coiled-coil α-helical rod protein 1 (CCHCR1) by siRNA and CRISPR-Cas9 significantly inhibits surface expression and signaling of α2A-adrenergic receptor (α2A-AR; also known as ADRA2A), without affecting α2B-AR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!